Share

Coronavirus, Galli: "It will last another 3 months, if all goes well"

According to the head of the infectious diseases department of the Sacco hospital in Milan, the coronavirus emergency "is not and will not be short-lived: it will last at least another three months"

Coronavirus, Galli: "It will last another 3 months, if all goes well"

In Italy the coronavirus emergency will last at least another three months. He supports it Massimo Galli, head of the infectious diseases department of the Sacco hospital in Milan. “My hope – said the Professor in an interview with CEI television, Tv2000 – is that we can get rid of this virus in no more than 3 months from the moment certain rules are applied. And I have already given a chilling term. It is not and will not be a short thing, if it ends soon I will be the first to have a party”.

Three months is the same amount of time it took the Chinese city of Wuhan – where the world's first outbreak of Covid19 exploded – to tame the epidemic, to the point of registering zero new infected on Thursday 19 March. However, China has implemented even more stringent measures - and complied with them with greater discipline - than what is happening in Italy. Not surprisingly, our country has already surpassed the Asian giant in the number of deaths and the Conte government is studying a new tightening of anti-coronavirus restrictions.

Moreover, Galli points out that Italy is not counting "all infected people", but only those "who have important symptoms". And this, "from an epidemiological point of view, does not put us in a position to have absolute confidence in the evaluation of the observed data to define when will it peak".

Sul coronavirus vaccine, Galli recalls that "there are at least 18 programs open", but also underlines that "to be lucky, it will arrive after the summer, not before".

As for the drugs that are used against the coronavirus, "let's go by trial and error - continues the chief physician - The use of chloroquine, an antimalarial drug, is a bit what we always do in the absence of anything else in the rather vague hypothesis that it might work. We started trials on the drug Remdesivir to really learn more and we used a lot of it as a drug granted outside of studies for compassionate use ".

comments